<DOC>
	<DOCNO>NCT01992172</DOCNO>
	<brief_summary>Photocil topical drug ( cream ) selectively deliver Narrow Band - Ultraviolet B ( NB-UVB ) therapy expose sunlight . Photocil intend help protect user non-therapeutic Ultraviolet B ( UVB ) radiation selectively passing wavelength light NB-UVB range peak transmission 308nm . The aim study assess safety efficacy Photocil treatment atopic dermatitis .</brief_summary>
	<brief_title>Photocil ( Topical ) Treatment Atopic Dermatitis</brief_title>
	<detailed_description>NB-UVB phototherapy common treatment patient atopic dermatitis , report safe effective numerous clinical trial . Clinical trial report achievement Atopic Dermatitis Area Severity Index ( ADASI ) -75 50-70 % patient 4-6 week NB-UVB treatment . Many drawback limit patient compliance , access , acceptance traditional NB-UVB phototherapy . The strict treatment regimen ( 2-3 session per week average 12 week ) perform specialized phototherapy clinic combine high cost low reimbursement make compliance access major drawback . In order address drawback phototherapy , develop novel topical cream - Photocil - selectively deliver NB-UVB therapy expose sunlight . When used natural sunlight , Photocil provide convenient alternative traditional clinic base phototherapy ; thus , potential dramatically increase patient compliance treatment outcome .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Sunscreening Agents</mesh_term>
	<criteria>Diagnosed atopic dermatitis confirm dermatologist Atopic dermatitis lesion affect minimum 5 % facial , legs , arm surface area Age : 18 65 Participants able give inform consent Subject respond prior phototherapy treatment Subject complete phototherapy lesion ( ) last 6 month Subject previous history skin cancer Subject previous history photosensitivity Subject history herpes ( HSV I II ) outbreaks Subject previous history autoimmune disease may exclude investigator 's discretion Subject currently take immunosuppressive photosensitizing drug Subject plan use antibiotic , antifungal , calcineurin inhibitor drug may cause photosensitivity study period . These patient may exclude investigator 's discretion Subject pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>